Related Experiment Videos
Fas function and tumor progression: use it and lose it.
1Department of Biomedical Sciences, University of California, Riverside, Riverside, California 92521, USA. laurie.owen-schaub@ucr.edu
Cancer Cell
|September 3, 2002
Summary
Fas and FasL interactions are crucial for controlling malignant diseases. Modulating Fas expression levels influences immune escape and treatment effectiveness in cancer.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Fas (also known as CD95 or APO-1) and its ligand (FasL) are key mediators of apoptosis.
- Dysregulation of the Fas pathway is implicated in various diseases, including cancer.
Purpose of the Study:
- To investigate the role of Fas and FasL interactions in the context of malignant disease control.
- To understand how alterations in Fas expression impact immune surveillance and therapeutic outcomes.
Main Methods:
- Analysis of Fas and FasL expression levels in disease models.
- Studies on the functional consequences of modulating Fas expression.
Main Results:
- Evidence supporting the critical role of Fas and FasL in regulating malignant disease.
- Demonstration that changes in Fas expression levels correlate with immune escape mechanisms.
- Correlation between Fas expression and patient response to therapies.
Conclusions:
- Fas and FasL signaling pathways are integral to the immune system's control over cancer.
- Targeting Fas expression presents a potential strategy for overcoming immune evasion and improving cancer treatment efficacy.